Nephrogenic Systemic Fibrosis and Contrast Medium-Induced Nephropathy: A Choice between the Devil and the Deep Blue Sea for Patients with Reduced Renal Function?

References

• Grobner T. Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 2006; 21: 1104–8
   PubMed Web of Science ®Google Scholar
• Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, et al. Nephrogenic systemic fibrosis: suspected etiological role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17: 2359–62
   PubMed Web of Science ®Google Scholar
• Dawson P, Punwani S. Nephrogenic systemic fibrosis: non gadolinium options for the imaging of CKD/ESRD patients. Semin Dial 2008; 21: 160–5
   Google Scholar
• H Smith. Annals of the ICRP: 1990 recommendations of the International Commission on Radiologcal Protection. London: Pergamon Press; 1990. p. 176.
   Google Scholar
• Academic members of the Contrast Media Safety Committee. ESUR guidelines on contrast media, HS Thomsen, Webb, JAW. Contrast media. Safety issues and ESUR guidelines. Heidelberg: Springer; 2009; 229–42.
   Google Scholar
• Bartlett MJ, Bynevelt M. Acute contrast reaction management by radiologists: a local audit study. Austr Radiol 2003; 47: 363–7
   Google Scholar
• Lightfoot CB, Abraham RJ, Mammen T, Abdolell M, Kapur S, Abraham RJ. Survey of radiologists’ knowledge regarding management of severe contrast material-induced allergic reactions. Radiology 2009; 251: 691–6
   Google Scholar
• Morcos SK. Dialysis and contrast media. Contrast media. Safety issues and ESUR guidelines, HS Thomsen, JAW Webb. Springer, Heidelberg 2009; 81–5
   Google Scholar
• Thomsen HS, Morcos SK, Barrett BJ. Contrast-induced nephropathy: the wheel has turned 360 degrees. Acta Radiol 2008; 49: 646–57
   PubMed Web of Science ®Google Scholar
• Thomsen HS. Contrast medium induced nephropathy. Contrast media. Safety issues and ESUR guidelines, HS Thomsen, JAW Webb. Springer, Heidelberg 2009; 63–80
   Google Scholar
• Solomon RJ, Mehran R, Natarjan MK, Doucet S, Katholi RE, Staniloae CS, et al. Contrast-induced nephropathy and long-term advice events: cause and effect?. Clin J Am Soc Nephrol 2009; 4: 1162–9
   PubMed Web of Science ®Google Scholar
• Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003; 108: 2769–75
   PubMed Web of Science ®Google Scholar
• Thomsen HS, Marckmann P, Logager VB. Update on nephrogenic systemic fibrosis. Magn Reson Imaging Clin N Am 2008; 16: 551–60
   Google Scholar
• Stenver DI. Pharmacovigilance: what to do if you see an adverse reaction and the consequences. Eur J Radiol 2008; 66: 184–8
   Google Scholar
• Thomsen HS. Delayed reactions: nephrogenic systemic fibrosis. Contrast media. Safety issues and ESUR guidelines, HS Thomsen, JAW Webb. Springer, Heidelberg 2009; 187–96
   Google Scholar
• Thomsen HS, Marckmann P. Extracellular Gd-CA. Differences in prevalences of NSF. Eur J Radiol 2008; 66: 180–3
   PubMed Web of Science ®Google Scholar
• Marckmann P, Skov L, Rossen K, Thomsen HS. Clinical manifestations of gadodiamide-related nephrogenic systemic fibrosis. Clin Nephrol 2008; 69: 161–8
   Google Scholar
• Rydahl C, Thomsen HS, Marckmann P. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium(Gd)-containing magnetic resonance contrast agent. Invest Radiol 2008; 43: 65–75
   Google Scholar
• Todd DJ, Kagan A, Chibnik LB, Kay J. Cutaneous changes of nephrogenic systemic fibrosis. Predictor of early mortality and association with gadolinium exposure. Arthritis Rheumatol 2007; 56: 3433–41
   PubMedGoogle Scholar
• Wahba IM, Simpson EL, White K. Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature. Am J Transplant 2007; 7: 2425–32
   PubMed Web of Science ®Google Scholar
• Newhouse JH, Kho D, Rao QA. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. Am J Roentgenol 2008; 191: 376–82
   PubMed Web of Science ®Google Scholar